Irene Sulzbacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Irene Sulzbacher has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Susanna Lang
Clinical Institute of Pathology, University of Vienna Medical School, Vienna, Austria
4 shared publicationsAndreas Chott
Clinical Institute of Pathology, University of Vienna Medical School, Vienna, Austria
3 shared publicationsKlemens Trieb
Department of Orthopedics, University of Vienna Medical School, Vienna, Austria
3 shared publicationsPeter Birner
Clinical Institute of Pathology, University of Vienna Medical School, Vienna, Austria
3 shared publicationsE Pichlbauer
Clinical Institute of Pathology, University of Vienna, Medical School, Waehringer Guertel 18–20, A-1090 Vienna, Austria
1 shared publicationK Trieb
University Clinic of Orthopedics, University of Vienna
1 shared publication
Latest Publications
- 1 January 2003
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (1) , 66-71
Expression of Platelet-Derived Growth Factor-AA is Associated with Tumor Progression in Osteosarcoma
- 1 January 2003
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (1) , 66-71
Expression of Platelet-Derived Growth Factor-AA is Associated with Tumor Progression in Osteosarcoma
- 1 October 2002
- Published by Springer Nature in Virchows Archiv
- Vol. 441 (4) , 345-349
Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors
Osteopontin (OPN), one of the major non-collagenous proteins of bone matrix, is together with vascular endothelial growth factor (VEGF) a potent angiogenic protein. In this study we determined the expression of OPN in benign and malignant bone tumors and investigated the prognostic influence of OPN expression on the outcome of osteosarcoma patients. Fifty-seven osteosarcomas and 11 osteoblastomas as well as 5 bone specimens with remodeling sites were immunohistochemically analyzed for expression of OPN and VEGF. OPN was not detected in osteoblasts of remodeling sites. Osteoblastoma osteoblasts as well as osteoclastlike giant cells and osteosarcoma mononuclear cells showed variable staining. In osteosarcomas OPN and VEGF expression correlated with each other (r=0.390, P=0.003, Spearman's test). Although osteosarcoma patients with high VEGF expression showed a trend towards shorter overall survival (P=0.0841, log-rank test), OPN expression had no influence on patients overall or on disease-free survival. Our data indicate that expression of this protein might be upregulated in bone neoplasia. Although OPN expression correlates with VEGF expression in osteosarcomas, OPN expression does not provide predictive information about the outcome of osteosarcoma patients.
- 1 October 2002
- Published by Springer Nature in Virchows Archiv
- Vol. 441 (4) , 345-349
Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors
Osteopontin (OPN), one of the major non-collagenous proteins of bone matrix, is together with vascular endothelial growth factor (VEGF) a potent angiogenic protein. In this study we determined the expression of OPN in benign and malignant bone tumors and investigated the prognostic influence of OPN expression on the outcome of osteosarcoma patients. Fifty-seven osteosarcomas and 11 osteoblastomas as well as 5 bone specimens with remodeling sites were immunohistochemically analyzed for expression of OPN and VEGF. OPN was not detected in osteoblasts of remodeling sites. Osteoblastoma osteoblasts as well as osteoclastlike giant cells and osteosarcoma mononuclear cells showed variable staining. In osteosarcomas OPN and VEGF expression correlated with each other (r=0.390, P=0.003, Spearman's test). Although osteosarcoma patients with high VEGF expression showed a trend towards shorter overall survival (P=0.0841, log-rank test), OPN expression had no influence on patients overall or on disease-free survival. Our data indicate that expression of this protein might be upregulated in bone neoplasia. Although OPN expression correlates with VEGF expression in osteosarcomas, OPN expression does not provide predictive information about the outcome of osteosarcoma patients.
- Open Access
- 1 May 2002
- Published by BMJ in Journal of Clinical Pathology
- Vol. 55 (5) , 381-385
The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter
Aims: The expression of bone morphogenetic proteins (BMPs) was analysed in 47 osteosarcomas to determine differences in the expression of BMP subtypes and to correlate expression with response to chemotherapy, in addition to the disease free and overall survival of patients. Methods: The expression of BMPs was examined immunohistochemically in 47 biopsy specimens of osteosarcoma using commercially available antibodies against different subtypes (BMP-2/4 (A-20), BMP-3 (N-19), BMP-4 (N-19), BMP-5 (N-19), BMP-6 (N-19), BMP-7 (N-19), BMP-8 (N-19)). The avidin–biotin–immunoperoxidase method was used for all antibodies. Results: The expression of BMP subtypes varied considerably: 28 of the 47 tumours expressed BMP-2/4, 24 expressed BMP-3, 41 expressed BMP-5, 31 expressed BMP-6, 43 expressed BMP-7, and 42 expressed BMP-8. High expression of BMP-6 was found in those parts of the osteosarcoma with a chondroid differentiation (p = 0.016, Mann-Whitney test). No correlation was observed between the response to chemotherapy and the expression of BMPs (p > 0.05, Mann-Whitney test). Univariate analysis showed no correlation between overall survival or progression free survival and the expression of BMPs (p > 0.05, log rank test). Conclusions: BMP-7 and BMP-8 are highly expressed in osteosarcoma. Moreover, high expression of BMP-6 correlates with a chondroid differentiation. In contrast to conclusions derived from previous studies in which small numbers of tumours were investigated, these results indicate that the expression of BMPs does not help to predict the outcome of patients.
- 1 May 2002
- Published by BMJ in Journal of Clinical Pathology
- Vol. 55 (5) , 381-385
Open AccessThe expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter
Aims: The expression of bone morphogenetic proteins (BMPs) was analysed in 47 osteosarcomas to determine differences in the expression of BMP subtypes and to correlate expression with response to chemotherapy, in addition to the disease free and overall survival of patients. Methods: The expression of BMPs was examined immunohistochemically in 47 biopsy specimens of osteosarcoma using commercially available antibodies against different subtypes (BMP-2/4 (A-20), BMP-3 (N-19), BMP-4 (N-19), BMP-5 (N-19), BMP-6 (N-19), BMP-7 (N-19), BMP-8 (N-19)). The avidin–biotin–immunoperoxidase method was used for all antibodies. Results: The expression of BMP subtypes varied considerably: 28 of the 47 tumours expressed BMP-2/4, 24 expressed BMP-3, 41 expressed BMP-5, 31 expressed BMP-6, 43 expressed BMP-7, and 42 expressed BMP-8. High expression of BMP-6 was found in those parts of the osteosarcoma with a chondroid differentiation (p = 0.016, Mann-Whitney test). No correlation was observed between the response to chemotherapy and the expression of BMPs (p > 0.05, Mann-Whitney test). Univariate analysis showed no correlation between overall survival or progression free survival and the expression of BMPs (p > 0.05, log rank test). Conclusions: BMP-7 and BMP-8 are highly expressed in osteosarcoma. Moreover, high expression of BMP-6 correlates with a chondroid differentiation. In contrast to conclusions derived from previous studies in which small numbers of tumours were investigated, these results indicate that the expression of BMPs does not help to predict the outcome of patients.
- 1 December 2001
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 25 (12) , 1520-1527
Platelet-Derived Growth Factor-α Receptor Expression Supports the Growth of Conventional Chondrosarcoma and Is Associated With Adverse Outcome
Bone cells are important targets of platelet-derived growth factors (PDGFs) because they stimulate proliferation of osteoblasts and chondrocytes. In this study we wanted to determine the expression of PDGF-AA and PDGF-alpha receptor in conventional chondrosarcomas and to compare the results with those obtained from benign enchondromas and non-neoplastic cartilage tissue. Sixty-seven chondrosarcomas, 20 enchondromas, and 5 specimens of healthy cartilage as well as 7 specimens of hypertrophic callus cartilage were immunohistochemically analyzed for the expression of PDGF-AA and PDGF-alpha receptor, respectively. Additionally, the proliferation activity was examined with the MIB-1 antibody. Clinical follow-up data were available from 53 patients. A significant overexpression of receptor and factor was found in chondrosarcomas as compared with enchondromas (PDGF-AA p = 0.013, PDGF-alpha receptor p <0.001). MIB-1 values were significantly higher in chondrosarcomas (p <0.001). In healthy joint cartilage no staining was detectable, whereas reactive cartilage of callus formation showed high expression levels. PDGF-alpha receptor expression was significantly higher in grade 3 chondrosarcomas compared with grade 2 (p = 0.022) and grade 1 tumors (p = 0.002). Survival analysis documented a significantly shorter overall survival for patients with high PDGF-alpha receptor expression (p = 0.0172, log-rank test). Because PDGF-alpha receptor expression positively correlates with the aggressiveness of chondrosarcoma, it may be considered as a possible target for novel therapeutic strategies.
- 1 December 2001
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 25 (12) , 1520-1527
Platelet-Derived Growth Factor-α Receptor Expression Supports the Growth of Conventional Chondrosarcoma and Is Associated With Adverse Outcome
Bone cells are important targets of platelet-derived growth factors (PDGFs) because they stimulate proliferation of osteoblasts and chondrocytes. In this study we wanted to determine the expression of PDGF-AA and PDGF-alpha receptor in conventional chondrosarcomas and to compare the results with those obtained from benign enchondromas and non-neoplastic cartilage tissue. Sixty-seven chondrosarcomas, 20 enchondromas, and 5 specimens of healthy cartilage as well as 7 specimens of hypertrophic callus cartilage were immunohistochemically analyzed for the expression of PDGF-AA and PDGF-alpha receptor, respectively. Additionally, the proliferation activity was examined with the MIB-1 antibody. Clinical follow-up data were available from 53 patients. A significant overexpression of receptor and factor was found in chondrosarcomas as compared with enchondromas (PDGF-AA p = 0.013, PDGF-alpha receptor p <0.001). MIB-1 values were significantly higher in chondrosarcomas (p <0.001). In healthy joint cartilage no staining was detectable, whereas reactive cartilage of callus formation showed high expression levels. PDGF-alpha receptor expression was significantly higher in grade 3 chondrosarcomas compared with grade 2 (p = 0.022) and grade 1 tumors (p = 0.002). Survival analysis documented a significantly shorter overall survival for patients with high PDGF-alpha receptor expression (p = 0.0172, log-rank test). Because PDGF-alpha receptor expression positively correlates with the aggressiveness of chondrosarcoma, it may be considered as a possible target for novel therapeutic strategies.
- 15 December 2000
- Published by Springer Nature in Der Radiologe
- Vol. 40 (12) , 1126-1133
Arthrose - Histologie und pathogenetische Ansätze
Die Arthrosis deformans ist die häufigste Gelenkerkrankung und betrifft über 60% der älteren Population. Die Erkrankung ist durch fortschreitenden Knorpelverlust gekennzeichnet und führt zu einer limitierterten Bewegungsfreiheit. In den meisten Fällen beginnt der Krankheitsverlauf heimtückisch ohne ersichtlichen Grund. Diese primäre Form manifestiert sich oft polyartikulär und betrifft vor allem die Hüfte, das Knie, die Halswirbelsäule, die interphalangealen Gelenke der Finger oder die tarsometatarsalen Gelenke. Bei einer zugrunde liegenden systemischen Erkrankung oder lokal destruierenden Faktoren ist der Knorpelabbau als sekundäre Arthrose zu bezeichnen. Die Pathogenese der primären Arthrose basiert auf einer intrinsischen Erkrankung des Knorpels, bei der biochemische und metabolische Veränderungen zu einem Zusammenbruch führen. In den letzten Jahrzehnten wurden jedoch auch Modelle entworfen, die andere Gelenkanteile wie Knochen oder den Bandapparat in den Mittelpunkt der Genese stellten. Veränderungen des subchondralen Knochens, die dem Knorpelabbau vorangingen, wurden beschrieben, und lenkten die Aufmerksamkeit auf diese Region als Ort des primären Geschehens. Andere Untersuchungen konzentrierten sich auf die metabolische Aktivität der Chondrozyten im unveränderten Knorpelgewebe von Arthrosepatienten. Der ausschlaggebende Faktor für den Krankheitsbeginn ist jedoch immer noch unklar. Dieser Übersichtsartikel beschreibt die morphologischen Veränderungen in Abhängigkeit des Krankheitsstadiums und versucht einen Einblick über verschiedene pathogenetischen Konzepte zu schaffen. Osteoarthitis is the most common joint disease affecting over 60% of the elderly population. It is characterized by the progressive erosion of articular cartilage leading to incapacity of movement. In the great majority of instances, osteoarthritis appears insidiously, without apparent initiating cause. This primary form is usually oligoarticular involving hip, knee, cervical vertebrae, interphalangeal joints of the fingers or tarsometatarsal joints of the feet. In case of an underlying systemic diasease or local injury the cartilage destruction is considered as secondary osteoarthritis. The pathogenesis of primary osteoarthritis suggests an intrinsic disease of cartilage in which biochemical and metabolic alterations result in its breakdown. Within the last decades different models were established which also concentrated on other joint structures such as bone or ligaments. Changes of the subchondral bone were found to precide cartilage damage suggesting a primary alteration of the subchondral region. Other studies concentrated on the metabolic activity of chondrocytes in healthy cartilage of osteoarthritis patients. The precise event that leads to these changes is still not clear. This review concentrates on the histological features in the course of the disease and tries to provide a summary on different pathogenetic concepts.
- 15 December 2000
- Published by Springer Nature in Der Radiologe
- Vol. 40 (12) , 1126-1133
Arthrose - Histologie und pathogenetische Ansätze
Die Arthrosis deformans ist die häufigste Gelenkerkrankung und betrifft über 60% der älteren Population. Die Erkrankung ist durch fortschreitenden Knorpelverlust gekennzeichnet und führt zu einer limitierterten Bewegungsfreiheit. In den meisten Fällen beginnt der Krankheitsverlauf heimtückisch ohne ersichtlichen Grund. Diese primäre Form manifestiert sich oft polyartikulär und betrifft vor allem die Hüfte, das Knie, die Halswirbelsäule, die interphalangealen Gelenke der Finger oder die tarsometatarsalen Gelenke. Bei einer zugrunde liegenden systemischen Erkrankung oder lokal destruierenden Faktoren ist der Knorpelabbau als sekundäre Arthrose zu bezeichnen. Die Pathogenese der primären Arthrose basiert auf einer intrinsischen Erkrankung des Knorpels, bei der biochemische und metabolische Veränderungen zu einem Zusammenbruch führen. In den letzten Jahrzehnten wurden jedoch auch Modelle entworfen, die andere Gelenkanteile wie Knochen oder den Bandapparat in den Mittelpunkt der Genese stellten. Veränderungen des subchondralen Knochens, die dem Knorpelabbau vorangingen, wurden beschrieben, und lenkten die Aufmerksamkeit auf diese Region als Ort des primären Geschehens. Andere Untersuchungen konzentrierten sich auf die metabolische Aktivität der Chondrozyten im unveränderten Knorpelgewebe von Arthrosepatienten. Der ausschlaggebende Faktor für den Krankheitsbeginn ist jedoch immer noch unklar. Dieser Übersichtsartikel beschreibt die morphologischen Veränderungen in Abhängigkeit des Krankheitsstadiums und versucht einen Einblick über verschiedene pathogenetischen Konzepte zu schaffen. Osteoarthitis is the most common joint disease affecting over 60% of the elderly population. It is characterized by the progressive erosion of articular cartilage leading to incapacity of movement. In the great majority of instances, osteoarthritis appears insidiously, without apparent initiating cause. This primary form is usually oligoarticular involving hip, knee, cervical vertebrae, interphalangeal joints of the fingers or tarsometatarsal joints of the feet. In case of an underlying systemic diasease or local injury the cartilage destruction is considered as secondary osteoarthritis. The pathogenesis of primary osteoarthritis suggests an intrinsic disease of cartilage in which biochemical and metabolic alterations result in its breakdown. Within the last decades different models were established which also concentrated on other joint structures such as bone or ligaments. Changes of the subchondral bone were found to precide cartilage damage suggesting a primary alteration of the subchondral region. Other studies concentrated on the metabolic activity of chondrocytes in healthy cartilage of osteoarthritis patients. The precise event that leads to these changes is still not clear. This review concentrates on the histological features in the course of the disease and tries to provide a summary on different pathogenetic concepts.
- Open Access
- 1 August 2000
- Published by Wiley in Pathology International
- Vol. 50 (8) , 667-671
Periosteal osteoblastoma: A case report and a review of the literature
Osteoblastomas located on the surface of cortical bone, so‐called periosteal (juxtacortical) osteoblastomas, are extremely rare. A 24‐year‐old man complained of pain and swelling in the left knee. The clinical and radiological investigation showed a tumor located in the posterior portion of the distal shaft of the femur. The radiological differential diagnosis included parosteal osteosarcoma, periosteal chondroma and periostitis ossificans. A frozen section was obtained and histology revealed an osteoblastoma with large epithelioid‐appearing osteoblasts consistent with an aggressive osteoblastoma. An en bloc resection of the tumor was performed and the definitive histology of the whole specimen revealed a typical osteoblastoma. The authors draw attention to the fact that periosteal osteoblastoma is a rare tumor that could be mistaken clinically and histologically for other and more common tumors at this location.
- 1 August 2000
- Published by Wiley in Pathology International
- Vol. 50 (8) , 667-671
Open AccessPeriosteal osteoblastoma: A case report and a review of the literature
Osteoblastomas located on the surface of cortical bone, so‐called periosteal (juxtacortical) osteoblastomas, are extremely rare. A 24‐year‐old man complained of pain and swelling in the left knee. The clinical and radiological investigation showed a tumor located in the posterior portion of the distal shaft of the femur. The radiological differential diagnosis included parosteal osteosarcoma, periosteal chondroma and periostitis ossificans. A frozen section was obtained and histology revealed an osteoblastoma with large epithelioid‐appearing osteoblasts consistent with an aggressive osteoblastoma. An en bloc resection of the tumor was performed and the definitive histology of the whole specimen revealed a typical osteoblastoma. The authors draw attention to the fact that periosteal osteoblastoma is a rare tumor that could be mistaken clinically and histologically for other and more common tumors at this location.